ASH 2014

06–09 December 2014 | San Francisco, CA

ASH 2014

06–09 December 2014 | San Francisco, CA
ASH 2014: The management of CLL 3:13
ASH 2014: The management of CLL
George Follows
Brentuximib vedotin therapy for Hodgkin lymphoma 2:18
Brentuximib vedotin therapy for Hodgkin lymphoma
Anton Hagenbeek • 9 Dec 2014
Prof Claire Harrison at ASH 2014 Highlights on myeloproliferative neoplasms 4:08
Prof Claire Harrison at ASH 2014 Highlights on myeloproliferative neoplasms
Claire Harrison
ASH 2014: Phase II/III study of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma 4:47
ASH 2014: Phase II/III study of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma
Andrew Davies • 6 Dec 2013
ASH 2014: Ask the experts Q&A session 2 13:25
ASH 2014: Ask the experts Q&A session 2
Brent Wood et al. • 6 Dec 2014
ASH 2014: Ask the experts Q&A session 1 23:35
ASH 2014: Ask the experts Q&A session 1
Catherine Bollard et al. • 6 Dec 2014
Progress in the development of treatments for leukemia 2:57
Progress in the development of treatments for leukemia
Robin Foà • 5 Sep 2014
Trial shows CAR T-cell therapy prolongs remission in paediatric relapsed or refractory ALL 6:42
Trial shows CAR T-cell therapy prolongs remission in paediatric relapsed or refractory ALL
Stephan Grupp • 5 Dec 2014
Paediatric treatment regimens for acute lymphoblastic leukaemia in adolescents and young adults 6:42
Paediatric treatment regimens for acute lymphoblastic leukaemia in adolescents and young adults
Wendy Stock • 5 Dec 2014
Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia 6:43
Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia
Oliver Ottmann • 5 Dec 2014
Phase III study shows tailored treatment improves response in T-lymphocytic leukemia 5:38
Phase III study shows tailored treatment improves response in T-lymphocytic leukemia
Brent Wood • 5 Dec 2014
Clinical trial supports autologous stem cell transplantion in HIV-associated lymphoma 5:40
Clinical trial supports autologous stem cell transplantion in HIV-associated lymphoma
Joseph Alvarnas • 5 Dec 2014
ASH 2014: Phase II study of lenalidomide plus rituximab for mantle cell lymphoma (Part 2) 2:48
ASH 2014: Phase II study of lenalidomide plus rituximab for mantle cell lymphoma (Part 2)
Jia Ruan • 5 Dec 2014
ASH 2014: Phase II study of lenalidomide plus rituximab for mantle cell lymphoma (Part 1) 4:38
ASH 2014: Phase II study of lenalidomide plus rituximab for mantle cell lymphoma (Part 1)
Jia Ruan • 5 Dec 2014
ASH 2014: Novel treatments for mantle cell lymphoma 2:27
ASH 2014: Novel treatments for mantle cell lymphoma
Jia Ruan • 5 Dec 2014
ASH 2014: Treating mantle cell lymphoma (Part 3) 2:21
ASH 2014: Treating mantle cell lymphoma (Part 3)
Andre Goy et al. • 5 Dec 2014
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals